{{The numbers are quite different, especially in the case of Tyrosine (8.3% vs. 9.2% respectively which is a ~10% deviation). Does this mean that the similarity required by the FDA has some flexibilities?}}
We would need to know what the batch to batch variation Teva had when they received FDA approval for Copaxone.